Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Sulfasalazine promotes recovery from liver fibrosis

Jan. 28, 2005

Metabasis Therapeutics extends and expands Merck & Co. hepatitis C collaboration

Jan. 28, 2005

New compounds for the treatment of HCV infections

Jan. 27, 2005

Update on the efficacy and safety of viramidine in chronic hepatitis C

Jan. 24, 2005

Improved gastrointestinal recovery found with MNTX after abdominal surgery

Jan. 24, 2005

Depression reported to reduce the efficacy of IFN-alpha plus ribavirin in hepatitis C

Jan. 24, 2005

Pegasys receives positive opinion in E.U. for hepatitis B

Jan. 24, 2005

Enzo Biochem receives grant to conduct study of EGS-21 for fatty liver disease

Jan. 20, 2005

First clinical data on the efficacy of peginterferon alfa-2b monotherapy in chronic hepatitis B

Jan. 18, 2005

Update on the safety and antiviral effects of Actilon in hepatitis C

Jan. 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...